VF
ACHV icon

Virtu Financial’s Achieve Life Sciences ACHV Stock Holding History

Virtu Financial’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,930
Closed -$59K – 1234
2024
Q1 		$59K Buy
+12,930
New +$57.4K ﹤0.01% 995
2021
Q4 		– Sell
-10,039
Closed -$85K – 1644
2021
Q3 		$85K Buy
+10,039
New +$78.8K 0.01% 1187
2019
Q4 		$25K Buy
2,400
+428
+22% +$9.18K ﹤0.01% 1292
2019
Q3 		$67K Sell
1,972
-1,001
-34% -$39.3K 0.01% 1151
2019
Q2 		$115K Buy
+2,973
New +$210K 0.01% 1113
2018
Q4 		– Sell
-1,309
Closed -$82K – 1508
2018
Q3 		$82K Buy
1,309
+757
+137% +$47.9K 0.01% 1234
2018
Q2 		$42K Buy
+552
New +$113K ﹤0.01% 1784
2017
Q4 		– Sell
-83
Closed -$34K – 2304
2017
Q3 		$34K Buy
+83
New +$59.6K ﹤0.01% 2278

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Virtu Financial's ACHV Position: Q2 2024 in Review

Virtu Financial sold out of Achieve Life Sciences (ACHV) in Q2 2024, closing a stake of 12,930 shares — an estimated $59K sold.

Virtu Financial first reported a position in ACHV in Q3 2017 and held it in 8 quarters. The position peaked at $115K in Q2 2019. 56 funds tracked by Wall St. Rank hold ACHV as of Q2 2024.

  • Virtu Financial reported no remaining Achieve Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 12,930 Achieve Life Sciences shares in Q2 2024, an estimated $59K.
  • Virtu Financial first reported a position in Achieve Life Sciences in Q3 2017 and held it in 8 quarters.
  • Virtu Financial's Achieve Life Sciences position peaked at $115K in Q2 2019.
  • 56 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.